ClinTex CTI - Review. Alternative Treatment of the Future.

A wide range of actual applications of blockchain-technologies amaze with its diversity. Write in the comments your opinion about in what area blockchain can not function and why.

Today's topic is very specific, because it is related to clinical trials. Perhaps you have heard about this, or seen in TV-series: when a person is on the verge of life and death, and he is offered alternative medicine in the framework of voluntary consent, with a great risk to worsen the situation, but also it is the only chance to regain his health.This method of treatment requires a regular register of changes taking place with the patient, dispensing medications, etc.

The annual financing of the clinical trials market is more than 100 billion $. What about a separate unit, the drug is subject to a clinical trial, its estimated value is about half a billion dollars $

ClinTex aims to minimize the flow costs associated with various costs, introducing artificial intelligence and a blockchain with all its advantages. This is done to ensure the savings of lost funds, improve the quality of treatment, reduce the cost of the drug, monitor changes and predict situations.

About the project

ClinTex is a decentralized complex of dApps applications, a blockchain platform/register directed at the area of clinical trials with the aim of increasing their effectiveness and reducing the cost of medications.

The main goal of the startup is to increase the effectiveness of clinical trials. To implement this, the on a basis of platform was created 7 decentralized applications that act as tools that optimize the process of data collection and performance. To this end, ClinTex provides AI with predictive analytics functions with included machine learning from clinical trials that was done. The main goal is to prevent costly overruns that have become commonplace in this industry.

Operating principle

The principle of operation is in 7 dApps applications (modules), which are tools for performing all operations on the platform. They will be distributed among the workforce. This simplifies and optimizes all processes, and also fixes them in a special blockchain registry so that no action is left without a trace.

Current practice shows that most medical errors are simply ignored or not entered into the database, or modified, in order to preserve their careers and careers responsible persons. This also applies to drugs and their properties.

CTi-OEM is a module points to problematic areas, thanks to images, and also serves to determine the further process of clinical trials.
CTi-CDV is a module is provided for visualization of clinical data, indicating the problems that need to be changed, in one word: monitoring.
CTi-PDA is a module which will predict the presence of hidden risks and problems that may arise during clinical trials, for a timely response.
This is confirmed by FDA.CTi-RBM. This module also includes monitoring of risks, but the essence of this function is to monitor current and past similar data. And also about the peculiarities of certain reactions and diseases for assessing and forecasting risks and their warnings, which will allow pharmaceutical companies to make a decision on the introduction of the drug in advance.
CTi-PRR is the one of the key applications of which is to find new, in need of alternative treatment patients. CTi-PRR is associated with specialized sites with details about each of the patients, where also any interested potential patient can take the initiative and interest.
The CTi-SIM application (Site Investigator) is the base for the persons who will conduct the research, with an internal registration platform where new employees will be hired to pay for in the platform crypto currency.
CTi-VMM (supplier management). This is module includes management and generation of suppliers.

Storj.io will be an additional data store.

Conclusion

Financing of medicine will increase every year, new diseases, new symptoms, etc. will appear. Increased funding requires rational distribution and monitoring.

Changing the existing stagnant system is aimed at improving the quality of all further tests and the team understands this perfectly, since early, individuals of the team took part in this.

Similar startups associated with clinical trials, I did not meet in my practice. according to the developers, if they implement their technologies at the moment, then they will help the industry to change the distribution of finances globally. Considering the fact that the annual volume of the market is $ 100 billion, the team assures that for the first time it will help to save at least 1% of this amount (annually).

Project ratings:

https://icobazaar.com/v2/clintex-cti/review-and-rating
https://icobench.com/ico/clintex
https://icomarks.com/ico/clintex
https://icorating.com/ico/clintex-clx/
https://icoholder.com/en/clintex-24333
https://www.trackico.io/ico/clintex/

P.S. This material is posted for your reference. Not a financial advice. I do not encourage you to participate in any ICO. You need to understand and consider the high risks of investing in ICO. The content expresses the author's personal opinion. The author is not an expert in the field of block technology. Always conduct your own analysis before investing in any ICO.

Information resources of the project:

My Details: